| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Beijing SL Pharmaceutical Co. Ltd (SHE: 002038)
002038 Technical Analysis
1.5
| As on 9th Jun 2023 002038 STOCK Price closed @ 10.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 9.68 & Sell for SHORT-TERM with Stoploss of 10.43 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002038STOCK Price
| Open | 9.43 | Change | Price | % |
| High | 10.40 | 1 Day | 0.67 | 7.07 |
| Low | 9.38 | 1 Week | 0.69 | 7.29 |
| Close | 10.15 | 1 Month | 1.59 | 18.57 |
| Volume | 52980893 | 1 Year | -0.32 | -3.06 |
| 52 Week High 11.31 | 52 Week Low 7.83 | ||||
SHE China Most Active Stocks
| 000100 | 3.90 | 1.04% |
| 300315 | 6.32 | 19.92% |
| 002602 | 7.57 | 10.03% |
| 300459 | 6.89 | 4.71% |
| 000725 | 4.00 | 1.78% |
| 300002 | 14.07 | 9.92% |
| 300058 | 10.87 | 1.68% |
| 002354 | 7.41 | 4.66% |
| 300059 | 14.23 | -1.59% |
| 002292 | 11.19 | -4.44% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002038 Daily Charts |
002038 Intraday Charts |
Whats New @ Bazaartrend |
002038 Free Analysis |
|
|
002038 Important Levels Intraday
| RESISTANCE | 12.12 |
| RESISTANCE | 11.49 |
| RESISTANCE | 11.10 |
| RESISTANCE | 10.71 |
| SUPPORT | 9.59 |
| SUPPORT | 9.20 |
| SUPPORT | 8.81 |
| SUPPORT | 8.18 |
002038 Forecast May 2024
| 4th UP Forecast | 13.93 |
| 3rd UP Forecast | 12.72 |
| 2nd UP Forecast | 11.97 |
| 1st UP Forecast | 11.22 |
| 1st DOWN Forecast | 9.08 |
| 2nd DOWN Forecast | 8.33 |
| 3rd DOWN Forecast | 7.58 |
| 4th DOWN Forecast | 6.37 |
002038 Weekly Forecast
| 4th UP Forecast | 11.11 |
| 3rd UP Forecast | 10.80 |
| 2nd UP Forecast | 10.61 |
| 1st UP Forecast | 10.42 |
| 1st DOWN Forecast | 9.88 |
| 2nd DOWN Forecast | 9.69 |
| 3rd DOWN Forecast | 9.50 |
| 4th DOWN Forecast | 9.19 |
002038 Forecast2024
| 4th UP Forecast | 17.55 |
| 3rd UP Forecast | 15.18 |
| 2nd UP Forecast | 13.71 |
| 1st UP Forecast | 12.24 |
| 1st DOWN Forecast | 8.06 |
| 2nd DOWN Forecast | 6.59 |
| 3rd DOWN Forecast | 5.12 |
| 4th DOWN Forecast | 2.75 |
Beijing SL Pharmaceutical Co. Ltd ( SHE China Symbol : 002038 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002038 Business Profile
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, develops and markets genetic engineering drugs in the People's Republic of China and internationally. The company primarily provides its products in the areas of oncology, hepatopathy, and senile diseases. It offers oncology products for neutropenia, thrombocytopenia, oophoroma, breast cancer, non-small cell lung cancer, head and neck cancer, oesophagus cancer, and seminoma, leukemia, malignant lymphoma, malignant melanoma, nausea and vomit, pancreatic cancer, carcinoma of bladder, brain gliomas, multiple myeloma, and other entity cancer. The company also provides organ transplantation products for prevention of rejection organ or marrow transplantation, earlier prevention and therapy of graft versus host disease, and renal homo transplantation rejection and intractable rejection; and wound management products for chronic cutaneous ulcer and burn wounds, as well as cardiovascular products for preventing and treating deep vein thrombosis or pulmonary embolism. In addition, it offers tablets for allergic disorders, insomnia, benign prostate hypertrophy and hypertension, varicella zoster virus, herpes simplex virus infection, genital herpes and relapse, sensitive organism infections, hepatitis B, hypercholesterolemia and coronary artery disease, and acute pain; and liver disease products for pancreatitis, upper digestive tract bleeding, and cholestasis, as well as APIs. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China. Address: No. 1 Building, Bitongyuan, Beijing, China, 100049
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service